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SUMMARY
Objectives-todeterminetheaccuracyofclinicaldiagnosisofDownsyndrome,identifyproblems
in reaching a diagnosis, to provide recommendations for improvement and estimate a minimum
prevalence for all types ofDown syndrome.
Design - A retrospective observational study was carried out over a five-year period. Genesis, a
databaselocatedintheDepartmentofMedicalgenetics, wasusedtoidentifythenumberofDown
syndrome karyotypes including trisomy, translocation, and mosaic sample variants. Age of
diagnosis was determined using date ofreceipt. Karyotyping requests for a clinical diagnosis of
Down syndrome werealsoidentified. Patientnotes and cytogenetic laboratory reports were used
to identify clinical indication for karyotyping.
Setting - Regional Genetics Centre, covering all cytogenetic analyses for referrals within the
entire Northern Ireland population.
Results -208 postnatal cases ofDown syndrome were identified, 197 (94.7%) trisomy, 3 (1.45%)
translocation, and 8(3.85%) mosaicvariants. 112 (54.8%) were male and 96(46.2%) female. 268
samples weretakentoconfirmorexclude aclinicaldiagnosisofDownsyndrome. 185 ofthese had
Downsyndrome, 77 werenormal, and6hadanotherabnormality. 90% and 100% oftrisomy and
translocation Down syndrome respectively were diagnosed on the basis ofclinical features. This
fell to 37.5% of mosaic Down syndrome patients being diagnosed clinically (p<0.001). Simian
crease, sandal gap, epicanthic folds, hypotonia, upslanting palpebral fissures, and protruding
tongue are the mostfrequent characteristic features seen. Similarly epicanthic folds, protruding
tongue, simian crease and sandal gap, hypotonia, and upslanting palpebral fissures are also
described in a significant proportion of karyotypically normal individuals, thus arousing a
suspicion ofDown syndrome. 89.4% ofpatients were diagnosed between day 1 and 7 of life. Of
10.6% patients diagnosed after day 7 oflife, 7.6% were adults and 3% children. The minimum
prevalence was estimated at 167.9 per 100,000, or 1 in 595 births.
Conclusion -Inadefinedpopulation,withaprevalenceofaround 1in600births,accurateclinical
diagnosis occurred in 90%, 100%, and 37.5% of trisomy, translocation, and mosaic patients.
49.5% ofpatients had one or more of the following phenotypic findings: Simian crease, sandal
gap,epicanthicfolds,hypotonia,upslantingpalpebralfissures,andprotrudingtongue.However,
the same six features aroused a suspicion of Down syndrome in individuals with normal
karyotyping, thus causing undue stress and worry to parents.
Mosaiccasesmaybemorecommonthanpreviouslyrecognised,andoftendonothavedysmorphic
features.Itisthereforeadiagnosisthatshouldalwaysbeconsideredinthosewhoareeducationally
subnormal without a definitive diagnosis.
INTRODUCTION
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investigated for Down syndrome on the basis of
a few clinical features.
Earlier clinical diagnosis allows parents to begin
to accept the diagnosis at an earlier stage, and in
some instances, make medical decisions about
life threatening events.4
The objectives of this study were to determine
accuracy of, and time taken to reach a clinical
diagnosis, to identify problems in reaching a
clinical diagnosis and provide some
recommendations for improvement, whilst
estimating the prevalence of the condition in a
well defined population.
METHODS/STUDY DESIGN
A retrospective observational study was carried
out over a five-year period from 01/01/97 -
31/12/01. Genesis, a genetic clinical and
laboratory records database inthe Department of
Medical Genetics that covers the entire Northern
Ireland population of 1.7 million, was used to
collect data on the following: number of Down
syndrome patients, including trisomy,
translocation and mosaic variants, the clinical
indication for karyotyping request, the ratio of
male to female Down syndrome patients, age at
diagnosis (using date ofreceipt), and number of
karyotyping requests for a clinical suspicion of
Down syndrome. A separate card index of all
chromosome disorders from 1971 was also
utilised, alongwith asearchoftheclinicalrecords
fromtheNorthernIrelandgenetics service(dating
back to 1969), and cross checking these with the
genesis records to achieve as complete an
ascertainment as possible within the defined
population of 1.7 million.
Patient notes and cytogenetic laboratory records
were then used to identify clinical features of
those who had undergone karyotyping for a
clinical suspicionofDown syndrome, and reason
for late diagnosis.
RESULTS
Weidentified210 cases ofDownsyndrome. Two
samples were from (prenatal) cordocentesis and
therefore excluded from further analysis.
Of 208 cases included in our study 197 (94.7%)
had full trisomy 21, three (1.45%) were
translocation, and 8 (3.85%) were mosaic Down
syndrome(Fig. 1). 112(54.8%) weremaleand96
(46.2%) female.
268 samples underwent karyotyping to confirm
orexclude aclinicaldiagnosisofDownsyndrome.
185 ofthesehadDownsyndrome, 77 werenormal
and 6 had another abnormality (Fig. 2.).
Clinical indication forkaryotyping of208 Down
syndrome samples was recorded, including the
breakdownfortrisomy,translocation,andmosaic
patients -Table I,90% oftrisomyDownsyndrome
and 100% oftranslocation Down syndrome were
diagnosed on the basis of clinical features. This
fell to 37.5% inmosaicDown syndromepatients.
StatisticalanalysisusingFishersexacttestshowed
a highly significant difference between mosaic
group andthe other two groups combined, inthat
mosaicDownsyndromeis moredifficulttodetect
clinically (p<0.001).
As well as indication forkaryotyping, individual
Trisomy, Translocation and Mosaic Down
syndrome
Fig 1. Number and type of Down syndrome
clinical features of each child with Down
syndrome were identified using karyotyping
requestformsandpatientnotes.In29% ofpatients
it was only stated that the patient had Down
syndrome and individual clinical features were
notnoted. Oftheremaining71% whohadclinical
features described, the frequency ofeach feature
was recorded and these were expressed as a
percentage.Themajorityofpatientshadnumerous
features described. The results are therefore
cumulative (Fig. 3).
We analysed the 77 patients with a normal
karyotyping result to see if we could identify
clinical features that may have been suggestive
of Down syndrome. In 13% no clinical features
were described and Down syndrome only was
C) The Ulster Medical Society, 2004.
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TABLE I
Trisomy, Translocation, and Mosaic Down Syndrome - Clinical Indicationfor Karyotyping
Clinical Indicationfor Total Trisomy Translocation Mosaic
Karyotyping (208) (197) (3) (8)
% No. % No. % No. % No.
DOWN SYNDROME - clinical suspicion of 88 183 90 177 100 3 37.5 3
Down Syndrome
DYSMORPHIC/MCA - two or more 7 15 7 14 0 0 12.5 1
dysmorphic features or multiple congenital
abnormalities
DEVELOPMENTAL DELAY 0.5 1 0 0 0 0 12.5 1
CHECK - repeat sample. Previous sample 1.5 3 1 2 0 0 12.5 1
identified Down Syndrome
CABNFH - chromosomal abnormality, 0.5 1 0.5 1 0 0 0 0
family history of
FLOPPY - hypotonia 0.5 1 0.5 1 0 0 0 0
OTHER - Noonan Syndrome 0.5 1 0 0 0 0 12.5 1
MENTAL RETARDATION 0.5 1 0 0 0 0 12.5 1
INTRAUTERINE GROWTH 1 2 1 2 0 0 0 0
RETARDATION
Results of Karyotyping on patients with
clinically suspected Down syndrome
stated. In theremaining 86% theclinical features
described were recorded and expressed as a
percentage of frequency (Fig. 4).
Age at diagnosis was calculated using date of
receipt ofsample to the Cytogenetic Laboratory.
186patients werediagnosedbetweenday 1 and 7
Fig 2. Results ofkaryotyping onpatients withclinically
suspected Down syndrome.
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Frequency of Clinical Features found in patients with Down syndrome - expressed as a
percentage
Figure 3
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Fig 3. Frequency of clinical features found from records ofpatients with Down syndrome - expressed as a percentage
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Frequency of Clinical Features suggestive of Down syndrome in patients with normal
Karyotyping - expressed as a percentage
Figure 4
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ABBREVIATIONS
AMNIO - Previously diagnosed with Down syndrome on
amniocentesis
B.N.B - Broad nasal bridge
CH.D - Congenital heart disease
D.D/M.R - Developmental delay / Mental retardation
D.P.F - Down slanting palpebral fissures
Dysmorphic -Dysmorphicfeaturesnoted, notdescribedindividually
EARS - Low set or dysmorphic ears
EPI. FOLDS - Epicanthic folds
F.H ofD.S - Family history ofDown syndrome (1st degree)
G.I OBST. - Gastrointestinal obstruction
I.U.G.R - Intrauterine growth retardation
MATERNAL AGE - Maternal age >30
MURMUR - Undiagnosed cardiac murmur
NECK - Short neck / increased nuchal skin thickness
OTHER - Other abnormality / diagnosis in the Down syndrome
group including:
- Macrocephaly
- Microcephaly
- Noonan Syndrome
- Renal abnormalities
- Short stature
- Swollen feet
- Talipes
- Umbilical hernia
- Wide spaced nipples
OTHER 1 - Other abnormality in group with normal karyotype
including:
- Atrioventricular septal defect
- Duodenal Atresia
- Hydrops Fetalis
- Talipes
- Tracheoesophageal fistula
P. ANXIETY - Parental Anxiety
PRETERM - < 37 weeks gestation
PRO. TONGUE - Protruding tongue
SIMIAN - Simian crease, unilateral/bilateral.
U.P.F - Upslanting palpebral fissures
Percentage of patients diagnosed with
Down syndrome between day I and day 7
of life
Fig 5. Percentage of patients diagnosed with Down
syndrome between day 1 and day 7 of life.
Infants, children and adults diagnosed
with Down syndrome after day 7 of life
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(89.4%). The breakdown of these patients is
shown as a percentage (Fig. 5). Ofthe 7 patients
diagnosed on day 6, two of these samples were
taken over a holiday period, thus accounting for
a slight delay in diagnosis. One sample on day 7
was also taken over a holiday period.
22 patients were diagnosed afterday 7 oflife. 16
(7.6%) adults and 6 (3%) children. These were
further sub-divided into trisomy (15),
translocation (1)andmosaic (6) DownSyndrome
(Fig. 6).
Threepatientsinthemosaic group werediagnosed
in childhood. One was diagnosed at 6 months of
lifeand wasclinicallyfelttobeNoonanSyndrome.
A second child in this group was diagnosed at 19
months andpresented withdevelopmental delay.
The third child had a sample sent at 7.5 years of
Fig 6. Infants, children andadults diagnosedwithDown
syndrome after day 7 of life.
age. This was acheck sample and nottime offirst
diagnosis. In the trisomy group a total of three
children were diagnosed after day 7 of life. One
infant was diagnosed at 23 days of life. Clinical
indicationforkaryotyping wasintrauterinegrowth
retardation. Another diagnosis was at 31 days of
life. This child presented with hypotonia and
bilateral simian creases. The third infant in this
group was a check sample sent at 37 days oflife.
All six children with a diagnosis later than day 7
of life were from different hospitals around the
Northern Ireland region, including the regional
neonatal centre. Baby checks are carried out by
different specialities and differentgrades ofstaff
in various hospitals.
The Ulster Medical Society, 2004.
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TABLE II
Abnormal results and their clinical interpretation
Results Clinical Interpretation
46, XXt (8; 12) (p23, 1; p13.1) pat Balanced translocation
46, XX, del (12) (pl2.2p 11.23) Partial deletion of chromosome 12
46, XX, inv (9) (p1 1q13) Normal female with variant
47, XXX Triple X
48, XXX +21 Triple X and trisomy 21
47, XX, +mar.ish Small bisatellited dicentric derivative 15
Of those diagnosed as adults, there were 12
trisomies, 3 mosaics, and 1 translocation Down
syndrome. Age in this group ranged from 18
years (1 patient), to 70 years of age (mean age
48). The majority ofthese patients, (11 trisomy,
1 mosaic, 1 translocation), were inpatients/
outpatients at Muckamore Abbey Hospital, a
regional specialist assessment centre for people
with learning disabilities. Samples of these
patients simply stated 'Down Syndrome'. One
patient presented at 18 years of life and was
described as educationally sub-normal without
dysmorphic features. This patient was a mosaic
Downsyndrome. Afurthermosaicpatientwas54
years of age at time of diagnosis and presented
with short stature, mental retardation and low
whitecell countwithpoormyeloidactivity inthe
bonemarrow. Onetrisomypatientwasdiagnosed
at54yearsofage.Notes wereunavailable.History
on therequestform stated thatthere was afamily
history oftranslocation.
Six karyotyping samples were found to be
abnormalbutnotDown syndromeTable 2. Inthe
sample group that was felt to be clinically Down
syndrome, two samples were unsuccessfully
karyotyped. One sample was in the wrong bottle
and the second was an unbanded analysis from
poor growth.
DISCUSSION
Based on the 5-yearperiodhaving identified 192
births inthe neonatalperiod, in apopulationtotal
of 114,307 live births, a minimum prevalence of
167.9 per 100,000 (or 1 in 595 births) was
calculated. This compares closely to previous
(lower) estimates of the prevalence of Down
syndromeandisanaccurateminimumprevalence
figure, taking into account the number ofmosaic
Down syndrome cases which are difficult to
calculate in the population which may not be
reflectedinotherlessaccurateprevalencefigures.
Ifwe include the cases diagnosed in adulthoodas
a proxy for missed cases of mosaic Down
syndrome yet to be recognised, (208), the figure
increases to 181.9per 100,000 (orapproximately
1 in 550 births).
Over the study period, 208 postnatal cases of
Down syndrome wereidentified. 94.7% trisomy,
1.45% translocation, and3.85% mosaic variants.
Expected ratios are 94% trisomy, 5%
translocation, and 1% mosaic variants.2 The
detection rate of mosaic variants is higher than
the standard quoted rates of 1-3%. Our study
includes a complete population, and newly
diagnosed adult cases, which may account for
this. Often mosaic variants do not have
dysmorphic features, and it is therefore
worthwhile to carry out a chromosomal analysis
on those who are educationally sub-normal
without dysmorphic features.
46% of our Down syndrome cases were female
and 54% male. The diagnosis was suspected
clinically in 88% of patients - 90% of trisomy
Down syndrome, 100% of translocation Down
syndrome, and only 37.5% of mosaic Down
syndrome.UsingFishersexacttestthisisahighly
significant result (p< 0.001) proving that mosaic
Downsyndromeismoredifficulttodetectleading
to a late diagnosis.
In patients with Down syndrome, simian crease,
sandal gap, epicanthic folds, hypotonia,
upslanting palpebral fissures, and protruding
tongue are the most frequent characteristics seen
C The Ulster Medical Society, 2004.
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andone ormore are foundin49.5% ofpatients in
ourstudy. Hall [5] describedtencardinalfeatures
of trisomy 21 in the newborn. These included
hypotonia, poorMoro reflex, hyper extensibility
of joints, excess skin on back of neck, slanted
palpebral fissures, and a flat facial profile. Hall
looked at trisomy 21 only, without including
mosaic or translocation Down syndrome. Our
study includes translocation and mosaic Down
syndrome and this may have accounted for the
difference in results. Interestingly, epicanthic
folds, protruding tongue, simian crease, sandal
gap,hypotonia, andupslanting palpebralfissures
arealsodescribedin53%ofkaryotypicallynormal
individuals thus arousing a suspicion of Down
syndrome, and28.7% ofallkaryotypingrequests
for clinically suspected Down syndrome were
normal.
The prevalence of Down syndrome in this study
compares well with other figures published
previously and is higher. Two reasons arefirstly,
that this study figure is consistent with a more
accurate figure inclusive of mosaic Down
syndrome rates and consistent with the higher
reported incidence ofmosaic Down syndrome of
around4% in this study, whencompared to older
studieswhereratesarearound 1-2%,andsecondly,
areflectionofthetrendforincreasingprevalence
of Down syndrome over the last 10 years due to
thetendencyforcouplestohavetheirbabieslater
in life.6
Recently, Hindley and Medakkar7 looked at
whichcriteriaarebeingusedtoreachadiagnostic
suspicion ofDown syndrome in neonates using a
questionnaire to cytogenetics laboratories in the
United Kingdom. They found poor recording of
characteristics of Down syndrome and almost
one third ofpossible diagnoses were negative on
karyotype.
Karyotyping request forms are not a completely
accurate method of ascertaining the clinical
features identified, or indeed present and not
identified, on the patient. Many forms simply
stated 'Down Syndrome' or 'clinical features of
Down Syndrome'. Some requests may haveonly
stated a few features elicited on the patient. The
forms however give an indication of the reasons
why samples are sent in or why the diagnosis of
Down syndrome may be suspected and allow
early diagnosis to be within 7 days and felt that
this was sufficientto account fordelay in sample
to arrive in the laboratory due to weekends or
holidayperiods. Afterday7theearliestdiagnosis
was 23 days oflife. Amore accuratemethodmay
have been to use date of sampling. 89.4% of
patients were diagnosed in the early period. Of
thosediagnosedafterdayseven,7.6%wereadults
andonly 3% children. Two children inthis group
werechecksamples meaningthatonly 6children
were diagnosed after day 7 oflife. All 6 children
were from different hospitals, thus baby checks
were being carried out by different grades of
staff. Numbers are not large enough to see any
difference in outcome of time to diagnosis
depending onwhoiscarrying outthebabycheck.
Thedetailsinthepatientnotesheldintheregional
geneticscentre, andrequestformsofthemajority
ofthose diagnosed as adults 13 were insufficient
to determine whether they were a check sample
or a first diagnosis. They may well have had a
clinicaldiagnosis,butchromosomalanalysiswas
notreadily availableatthetimeoffirstdiagnosis.
CONCLUSION
49.5% of patients had one or more of six
phenotypic findings: simian crease, sandal gap,
epicanthicfolds,hypotonia, upslantingpalpebral
fissures, and protruding tongue. Checking for
these six features will heighten suspicion of a
diagnosis ofDown syndrome and the chances of
abnormal karyotype. The overall minimum
prevalence in the population is around 1 in 600
births. Mosaic cases are more common than
previously recognised, and often do not have
dysmorphicfeatures,resultinginalaterdiagnosis
Mosaic Down syndrome should always be
considered in those who are educationally
subnormal but have no definitive diagnosis
accuracy and referral reasons to be compared.
Age at diagnosis was determined using date of
receiptofsampletothelaboratory. Weconsidered
C The Ulster Medical Society, 2004.
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